Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentJoseph Keane, M. Miles Braun, Robert P. Wise et al.|New England Journal of Medicine|2001Cited by 3.7k
Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanerceptJong‐Hoon Lee, M. Miles Braun, Robert P. Wise et al.|Arthritis & Rheumatism|2002Cited by 448
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.Weigong Zhou, Robert T. Chen, Penina Haber et al.|PubMed|2003Cited by 397
STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS AFTER VACCINATION: REPORTS TO THE VACCINE ADVERSE EVENT REPORTING SYSTEMRobert Ball, Marcel E. Salive, Robert P. Wise et al.|The Pediatric Infectious Disease Journal|2001Cited by 84